Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

ObjectivePlasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chu-Lin Chou, Shu-Hui Juan, Ching-Hao Li, Hsi-Hsien Chen, Chih-Chin Kao, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-05-01
Col·lecció:Frontiers in Oncology
Matèries:
DPP-4 inhibitors
colorectal cancer
liver cancer
second-line agents
type 2 diabetes mellitus
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2022.840142/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars